Clostridium is a large genus of obligate anaerobes belonging to the Firmicutes phylum of bacteria, most of which have a Gram-positive cell wall structure. The genus includes significant human and animal pathogens, causative of potentially deadly diseases such as tetanus and botulism. Despite their relevance and many studies suggesting that they are not a monophyletic group, the taxonomy of the group has largely been neglected. Currently, species belonging to the genus are placed in the unnatural order defined as Clostridiales, which includes the class Clostridia. Here we used genomic data from 779 strains to study the taxonomy and evolution of the group. This analysis allowed us to; (i) confirm that the group is composed of more than one genus (ii), detect major differences between pathogens classified as a single species within the group of authentic Clostridium spp. (sensu stricto), (iii) identify inconsistencies between taxonomy and toxin evolution that reflect on the pervasive misclassification of strains and, (iv) identify differential traits within central metabolism of members of what has been defined earlier and confirmed by us as cluster I. Our analysis shows that the current taxonomic classification of Clostridium species hinders the prediction of functions and traits, suggests a new classification for this fascinating class of bacteria and highlights the importance of phylogenomics for taxonomic studies.
General Taxonomy:
We first retrieved more than 1,700 genomes and draft genomes deposited as "Clostridium" and "Clostridioides" from the GenBank as of July 2017. The dataset was filtered by removing low quality genomes (genomes with more than 400 contigs) and by eliminating redundancy at the strain level.
This filtering resulted in a subset of 779 genomes (Supplementary Table S1 From this subset of genomes, we identified 27 conserved protein sequences (Supplementary Table   S2 ). These proteins do not represent the complete core genome of clostridia, instead, these proteins are a set of taxonomic markers that can confidently be used for the construction of a clostridial species tree ( Figure 1 ). This tree defined 7 major clades that were consistent with the previous established clostridial "clusters" classification (Rainey et al., 2006) . Accordingly, clusters III, IV, Xia, XIVa, XIVb, and XVI were distantly related to Cluster I (sensu stricto), which contains 370 strains including most toxin-producer pathogens and industrially relevant strains, but clearly excludes difficile species. Based on this analysis we defined the members of cluster I as the authentic members of the Clostridium genus. Furthermore, since cluster Xia has already been reclassified as Clostridioides sp.
we propose that the remaining 5 groups represent distinct new genera.
Cluster I was further divided into 17 subgroups (Table 1) using the species tree presented in Figure 1 Our analysis also showed that strains named C. botulinum are found in subgroups 1, 5 and 8 (Table   1) Figure S15) . The fact that C. sporogenes, C. novyi and C. haemolyticum species show little divergence with their respective C. botulinum relatives suggest that these strains are either artificially defined as distinct species or have just recently diverged. Together, these observations indicate that the strains defined as Clostridium botulinum should be split into three species found within groups 1, 5 and 8. C. botulinum strains in subgroups 1 and 5 may be called, C. sporogenes and C. haemolyticum, respectively, since these species have been previously defined, while strains within subgroup 8 may remain as members of the authentic C. botulinum species. However, as highlighted by Lawson (2016b) , changing names of medically relevant organisms can cause great confusion in the healthcare community. As these three species produce botulinum neurotoxins, the change of name might be rejected under Rule 56a (5) of the International Code of Nomenclature of Prokaryotes (Parker, Tindall, & Garrity, 2015) , which states that "names whose application is likely to lead to accidents endangering health or life or both" can be rejected.
As this analysis uses draft genomes to include as many genomes as possible, and only 27 proteins were conserved among these genomes, the analysis was repeated using a smaller subset of high quality genomes (179, N50>600 kbp) to validate our results. As such, a higher number of conserved proteins (79) were obtained and used (Supplementary Table S3 ). This new analysis (Supplementary Figure S16) showed that the taxonomic groups maintained the same distribution (tree topology) when using a dataset of 179 or 779 genomes and a matrix containing 79 or 27 protein sequences respectively. The same Clusters and Cluster I subgroups were observed (Supplementary Figure S16- S29), with the exception of clades that disappeared as they did not pass the stringent genome quality cut off (Cluster IV and XVI, and Subgroups 9, 13, 14 and 15 in Cluster I).
Toxin evolution:
Pathogenic clostridia produce the highest number of life-threatening toxins of any genus. This includes enterotoxins that affect the gut, such as C. difficile toxins A and B, histotoxins that affect soft tissue such as C. perfringens and C. septicum alpha-toxins, and neurotoxins affecting nervous tissue such as tetanus (C. tetani) and botulinum (C. botulinum) toxins. Diseases range from gastroenteritis to abdominal disorders, colitis, muscle necrosis, soft tissue infections, tetanus and botulism amongst others (Hatheway, 1990 ). These toxin-encoding genes are often located on mobile genetic elements or in variable regions of the chromosome (Hatheway, 1990 B, E and F do not. According with these observations, we suggest that toxin production should not be used to define taxonomic groups, as it uncouples taxonomy from phylogeny.
Core Genome analysis
Once the taxonomic framework was established, we used it to study the evolutionary dynamics and to identify general differences among the subgroups within Cluster I. For this purpose, we calculated core/pangenomes for each subgroup having more than 10 genomes (Table 1 ). This analysis ( Figure   3 ) showed that subgroups 3 (C. tetani), 5 (C. botulinum toxin group C and D, C. haemolyticum, and C. After establishing general differences between the evolutionary dynamics of the subgroups, we took a closer look at differences at the functional level. For this purpose, we extracted amino acid sequences of the core genes of each subgroup and identified conserved functions among them (i. e. a core of cores) and functions that are distinctive of each subgroup (Table 1 ). This analysis revealed that Cluster I has a core of 212 genes. As expected, many of these conserved genes are associated with housekeeping functions such as nucleotide biosynthesis, replication and repair (Supplementary Figure S33) . Unique genes were abundantly classified as members of carbohydrate metabolism and for membrane transport. Interestingly, the largest number of accessory functions were related to amino acid metabolism, implying that multiple genes for this category are conserved at the subgroup level only. This observation is illustrated by the example described in the following section.
Divergence of the shikimate pathway in pathogenic clostridia
To investigate adaptive traits that could define differences within each sub group, we mined the pangenomes for functions that were uniquely found in each group. From a taxonomic point of view, unique genomic traits are important as they can be used for the development of genetic markers and to identify distinctive phenotypes that can be used for classification. The rationale for searching unique traits within subgroups was that the use of such a large genomic database would enable, for the first time, to find unique functions conserved in all members of a subgroup but absent in other subgroups, thereby enabling to dissect for subgroup specific adaptations. This was the case for the essential enzyme 3-phosphoshikimate 1-carboxyvinyltransferase (AroA), which was found in the pangenome of Cluster I. AroA is part of the shikimate pathway and is essential for the biosynthesis of aromatic amino acids phenylalanine, tyrosine and tryptophan. This seemed unusual given that all subgroup cores include AroA.
We reasoned that the presence of AroA among the pangenome may be due to; (i) divergence among AroA orthologs beyond the cutoff for orthology defined in our pangenome strategy leading to fragmentation of the gene family, or (ii) duplication events in certain subgroups and divergence, which have been previously linked to adaptive evolution in bacteria (Schniete et al., 2018) . To explore this idea, we searched for homologs of the AroA enzyme in all the strains from Cluster I and found a single ortholog conserved in most strains. Thus, we assumed that AroA has divergently evolved within the Cluster I species. Studies have also shown that C. sporogenes, a soil bacterium rarely pathogenic for humans (Inkster et al, 2011) although it may be found in the gut, and C. botulinum (Cluster I), a toxin producing pathogen, copiously produce tryptophan, phenylalanine and tyrosine. It has been suggested that secretion of these amino acids and intermediates of its degradation may influence intestinal permeability and systemic immunity of the host (Dodd et al., 2018) . We speculate that the divergence in AroA may be related to the evolution of new metabolic interactions that do not affect the enzymatic activity of AroA, but rather its regulation in clostridial species that are able to colonise hosts. Given the presence of this trait in pathogen and commensal strains, we reasoned that this trait likely evolved prior to the acquisition of toxin genes. Following the same thought process, we suggest that C. botulinum subgroup 1 toxin groups A, B and F, have only recently evolved into pathogenic organisms.
By selecting amino acid biosynthesis to illustrate the use of the new classification, we show here that a correlation between traits, function gain and loss cannot be extracted from the current taxonomic classification of Clostridium species, and they remain unchanged. Through this effort, we hope that our work serves to inspire the research community to study the evolution of clostridia at the genomescale level and suggest a new classification for this fascinating class of bacteria.
Conclusions:
Here we present an inclusive framework for phylogenomic analysis aimed at providing an updated view of the Clostridium genus. Our work shows that the current definition of clostridia encompasses a large and diverse group of species that is inconsistent with its definition as a genus. Instead, the group includes multiple genera. Furthermore, within group I, arguably the authentic Clostridium clostridial taxonomy and evolution has not been revisited using the opportunity offered by next generation sequencing for phylogenomic reclassification until now. Given the pervasiveness of the misclassification in clostridial species, we wonder whether the current system of classification should be kept, or if it should be revisited and simplified using genomic data. The recent explosion of available annotated genomes offers an unprecedented opportunity to answer intriguing questions surrounding pathogenic clostridial evolution. For example, the incredible diversity and the number of toxins produced by some strains is yet to be fully understood. So is the astonishing potency of some of the toxins produced by these pathogens, which must confer an evolutionary advantage that remains to be elucidated.
Materials and methods:
All genomes were downloaded from the NCBI FTP site, filtered by the number of contigs, (cutoff <= 400) resulting in 779 genomes which were annotated in RAST (Aziz et al., 2008) . The conserved proteins present in the selected genomes were identified using BPGA v1.3 (Chaudhari et al., 2016) with an identity cutoff of 0.4 for clustering of groups of orthologs using Usearch (Edgar, 2010).
The resulting 27 groups of orthologs were aligned using Muscle v3. Table S1 ) was selected using the ModelFinder tool implemented in IQ-tree (Kalyaanamoorthy et al., 2017) and the phylogeny was constructed using IQ-tree (Nguyen et al., 2015) , using the partitioned models with 10,000 bootstrap replicates.
Pangenome analysis of Cluster I subgroups was performed using BPGA following the same approach described above. Homologs of BotA and AroA were mined and retrieved from the database using BlastP (Altschul et al., 1990) with an e-value cutoff of 1E-9 and bit score of 200. Phylogenetic trees for clostridial toxins and AroA were obtained using the same approach. Synteny analysis was performed Table S1 ) deposited in the GenBank database and taxonomically defined as Clostridium. The main clades outside and within (370 taxa) the sensu stricto group (real clostridia) have been collapsed and defined as 17 taxonomic subgroups (Table 1) . Branch support is shown at each node. Uncollapsed clades for subgroups 1-17 are shown in Supplementary Figures S1-S14. 
